Kardiaka 14 - Landiolol

By: INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE๐Ÿ“ Czech RepublicOpen

Key Information

ReferenceGB-559028-2026
DeadlineSep 15, 2026 12:00 AM
Estimated ValueCZK 39,769,000.00
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressCity : Praha Postal code : 14000 Telephone : +420 261365064 Country : Czechia
PublishedAug 12, 2026

Description

<br/>The subject of the public contract is the supply of medicinal products for parenteral application with the active substance landiolol (ATC C07AB14) for the treatment of patients in approved indic...

Full details are available after unlocking this tender.